Therapeutic efficacy of RU 28965 in respiratory tract infections

Seiichi Aonuma, Yutaka Tokue, Naoto Kitamura, Yoshihiro Honda, Reiko Ono, Akira Watanabe, Masako Sasaki, Kotaro Oizumi, Kiyoshi Konno, Yushi Nakai, Junichi Saito, Kosaku Nagai

    Research output: Contribution to journalArticlepeer-review


    RU 28965, a new macrolide antibiotic, was orally administered to 24 patients with upper and lower respiratory tract infections. Clinical response was excellent in 1, good in 12, fair in 4 and poor in 7 cases. Skin rash was observed in one patient, and slight elevation of transaminase in three.

    Original languageEnglish
    Pages (from-to)245-250
    Number of pages6
    Publication statusPublished - 1988

    ASJC Scopus subject areas

    • Pharmacology (medical)
    • Infectious Diseases
    • Pharmacology
    • Drug Discovery
    • Oncology


    Dive into the research topics of 'Therapeutic efficacy of RU 28965 in respiratory tract infections'. Together they form a unique fingerprint.

    Cite this